Development of hepatopulmonary syndrome and portopulmonary hypertension in a paediatric liver transplant patient

Pediatric Transplantation

Volumn 9, Issue 1, 2005, Pages 127-131

  Shah, Tahir ^a,b   Isaac, John ^a   Adams, David ^a   Kelly, Deirdre ^a  

^a BIRMINGHAM CHILDREN S HOSPITAL   (United Kingdom)

^b QUEEN ELIZABETH HOSPITAL   (United Kingdom)

Author keywords

Hepatopulmonary syndrome; Liver transplant; Portopulmonary hypertension

Indexed keywords

ARTICLE; BILE DUCT ATRESIA; BILIARY CIRRHOSIS; CASE REPORT; CHRONIC GRAFT REJECTION; DISEASE COURSE; HEART RIGHT VENTRICLE FAILURE; HEPATOPULMONARY SYNDROME; HUMAN; LIVER GRAFT REJECTION; LIVER TRANSPLANTATION; NEWBORN; PORTAL HYPERTENSION; PULMONARY HYPERTENSION;

ADOLESCENT; BILIARY ATRESIA; FEMALE; GRAFT REJECTION; HEPATOPULMONARY SYNDROME; HUMANS; HYPERTENSION, PORTAL; HYPERTENSION, PULMONARY; LIVER CIRRHOSIS, BILIARY; LIVER TRANSPLANTATION; REOPERATION;

EID: 13744262667     PISSN: 13973142     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1399-3046.2004.00221.x     Document Type: Article

References (24)

1. MAL H, BRUGIERE O, DURAND F, FARTOUKH M, COHEN-SOLAL A, FOURNIER M. Pulmonary hypertension following hepatopulmonary syndrome in a patient with cirrhosis. J Hepatology 1999: 31: 360-364.
2. MARTINEZ-PALLI G, BARBERA JA, TAURA P, CIRERA I, et al. Severe portopulmonary hypertension in a patient with pre-existing hepatopulmonary syndrome. J Hepatology 1999: 31: 1075-1079.
3. LANGE PA, STOLLER JK. The hepatopulmonary syndrome. Ann Int Med 1995: 122: 521-529.
4. RODRIGUEZ-ROISON R, AGUSTI A, ROCA J. The hepatopulmonary syndrome: New name, old complexities. Thorax 1992: 47: 897-902.
5. HADENGUE A, BENHAYOUN M, LEBREC D, BENHANOU J. Pulmonary hypertension complicating portal hypertension: Prevalence and relation to splanchnic haemodynamics. Gastroenterology 1991: 100: 520-528.
6. RUBIN L. Primary pulmonary hypertension: ACCP concensus statement. Chest 1993: 104: 236-250.
7. FALLON B. Portopulmonary hypertension: New clinical insights and more questions on pathogenesis. Hepatology 2003: 37: 253-255.
8. CASTRO M, KROWKA MJ. Hepatopulmonary syndrome: A pulmonary vascular complication of liver disease. Clin Chest Med 1996: 17: 35-48.
9. HERVE P, LEBREC D, BRENOT F, et al. Pulmonary vascular disorders in portal hypertension. Eur Resp J 1998: 11: 1153-1166.
10. BABBS C, WARNES TW, HABOUBI NH. Non-cirrhotic portal hypertension with hhypoxaemia. Gut 1988: 29: 129-131.
11. VETTUKATTIL JJ. Pathogenesis of pulmonary arteriovenous malformations: Role of hepatopulmonary interactions. Heart 2002: 88: 561-563.
12. RICH S. Clinical insights into the pathogenesis of primary pulmonary hypertension. Chest 1998: 114: 237S-241S.
13. FALLON MB, ABRAMS GA. Pulmonary dysfunction in chronic liver disease. Hepatology 2000: 32: 859-865.
14. NUNES H, LEBREC D, MAZMANIAN M, et al. Role of nitric oxide in hepatopulmonary syndrome in cirrhotic rats. Am J Respir Crit Care Med 2000: 164: 879-885.
15. CARTER EP, SATO K, MORIO Y, MCMURTRY F. Inhibition of K(Ca) channels restores blunted hypoxic pulmonary vasoconstriction in rats with cirrhosis. L903-L910. Am J Physiol Lung Cell Phsiol 2000: 279: 903-910.
16. ROBERT V, CHABOT F, VIAL B, GUIOT P, POUSSEL JF, POLU JM. Hepatopulmonary syndrome: Physiopathology of impaired gas exchange. Rev Mal Respir 1999: 16: 769-779.
17. LANGE PA, STOLLER JK. The hepatopulmonary syndrome: Effect of liver transplantation. Clin Chest Med 1996: 17: 115-123.
18. HOPKINS WE, WAGGONNER BA, BARZILAI B. Frequency and significance of intrapulmonary right-to-left shunting in end-stage hepatic disease. Am J Cardiol 1992: 70: 516-519.
19. ARGUEDAS MR, ABRAMS GA, KROWKA MJ, FALLON MB. Prospective evaluation of outcomes and predictors of mortality in patients with hepatopulmonary syndrome undergoing liver transplantation. Hepatology 2003: 37: 192-197.
20. KROWKA MJ, PLEVAK DJ, FINDLEY JY, ROSEN CB, WIESNER RH, KROM RA. Pulmonary haemodynamics and perioperative cardiopulmonary-related mortality in patients with portopulmonary hypertension undergoing liver transplantation. Liver Transpl 2000: 6: 451-452.
21. SAIKADA E, NAKASEKO C, HARIMA A, et al. Late-onset non-infectous pulmonary complications after allogeneic stem cell transplantation are significantly associated with chronic graft versus host disease and with the graft versus leukaemia effect. Blood 2003: 102: 4236-4242.
22. PRZEPIORKA D, ANDERLINI P, SALIBA R, et al. Chronic graft versus host disease after allogeneic blood stem cell transplantation. Blood 2001: 98: 1695-1700.
23. DEANGELO AJ, OUELLETTE D. Bronchiolitis obliterans organising pneumonia in an orthotopic liver transplant patient. Transplantation 2002: 73: 544-546.
24. FREUDENBERGER TD, MADTES DK, CURTIS R, CUMMINGS P, STORER BE, HACKMAN RC. Association between acute and chronic graft versus host disease and bronchiolitis obliterans organising pneumonia in recipients of hematopoietic stem cell transplants. Blood 2003: 102: 3822-3828.